In this study, we evaluated the sensitivity of the Omicron BA.2.75 subvariant to 10 therapeutic monoclonal antibodies: adintrevimab, bamlanivimab, bebtelovimab, casirivimab, cilgavimab,...
AUDIO: Removal of Sotrovimab Monoclonal Antibodies Is Premature
Recent Comments